Filing Details
Regen BioPharma Inc (OTC:RGBP) filed a Form 8-K with the Securities and Exchange Commission on November 02, 2026, disclosing a material event.
8k filedOTC:RGBP
Regen BioPharma Inc (RGBP) Reports Material Event to SEC
Regen BioPharma Inc (OTC:RGBP) filed a Form 8-K with the Securities and Exchange Commission on November 02, 2026, disclosing a material event.
At publication ·
What changed
Regen BioPharma Inc (OTC:RGBP) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Regen BioPharma Inc filed a Form 8-K on November 02, 2026 disclosing a material event to shareholders.
- The company's stock trades at $0.00 with a market capitalization of $189.3K.
- 8-K filings report material events such as leadership changes, acquisitions, asset sales, or financial guidance changes.
Market Context
Regen BioPharma Inc's stock currently trades at $0.00 with a market capitalization of $189.3K. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Regen BioPharma Inc's stock.
All SEC filings for Regen BioPharma Inc are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RGBP Stock Page
Frequently Asked Questions
Where can I read RGBP's SEC filings?
Browse all filings on our RGBP SEC filings page.
What types of SEC filings does Regen BioPharma Inc file?
Public companies like Regen BioPharma Inc file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.